Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL407721 | 0.81 | ALDH1A1 (0.38) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL12930022 | 0.77 | CYP2C9 (0.43) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL28924190 | 0.77 | MEN1 (0.36) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL140011 | 0.76 | CA1 (0.37) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL18802300 | 0.76 | CA1 (0.37) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL18806835 | 0.76 | CA1 (0.37) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL11998814 | 0.75 | CA1 (0.34) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL409808 | 0.75 | CA1 (0.41) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL10227709 | 0.74 | CCNA2 (0.40) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 | |
| SCHEMBL29196807 | 0.74 | CA1 (0.35) | MEN1KMT2ACYP2C9CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084062-A1 | SUBSTITUTED QUINOLINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2025-03-13 | — | — | US | disclosed |
| CN-113166151-A | Substituted xanthine derivatives | 勃林格殷格翰国际有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-108884093-B | Dopamine D3 ligand compound | 辉瑞公司 | 2021-07-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084062-A1 | SUBSTITUTED QUINOLINE DERIVATIVE | CHRNA4, CHRNA2, CHRNA5 | MEN1 3349/4885KMT2A 2084/4885CYP2C9 3729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.